EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status

Celeste M Donato iD, Amanda Handley, Sean G Byars, Nada Bogdanovic-Sakran, Eleanor A Lyons, Emma Watts, Darren S Ong, Daniel Pavlic, Jarir At Thobari, Cahya Dewi Satria, Hera Nirwati, Yati Soenarto und 1 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Celeste M Donato und 12 weiteren Autor:innen. Beteiligte Einrichtung: Enteric Diseases Group, Murdoch Children's Research Institute. Hauptthemen laut MEDLINE: Rotavirus Infections, Rotavirus Vaccines, Blood Group Antigens, Rotavirus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Bill & Melinda Gates Foundation, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Histo-blood group antigen (HBGA) status may affect vaccine efficacy due to rotavirus strains binding to HBGAs in a P genotype–dependent manner. This study aimed to determine if HBGA status affected vaccine take of the G3P[6] neonatal vaccine RV3-BB.

Methods

DNA was extracted from stool samples collected in a subset (n = 164) of the RV3-BB phase IIb trial in Indonesian infants. FUT2 and FUT3 genes were amplified and sequenced, with any single-nucleotide polymorphisms analyzed to infer Lewis and secretor status. Measures of positive cumulative vaccine take were defined as serum immune response (immunoglobulin A or serum-neutralizing antibody) and/or stool excretion of RV3-BB virus. Participants were stratified by HBGA status and measures of vaccine take.

Results

In 147 of 164 participants, Lewis and secretor phenotype were determined. Positive vaccine take was recorded for 144 (97.9%) of 147 participants with the combined phenotype determined. Cumulative vaccine take was not significantly associated with secretor status (relative risk, 1.00 [95% CI, .94–1.06]; P = .97) or Lewis phenotype (relative risk, 1.03 [95% CI, .94–1.14]; P = .33), nor was a difference observed when analyzed by each component of vaccine take.

Conclusions

The RV3-BB vaccine produced positive cumulative vaccine take, irrespective of HBGA status in Indonesian infants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rotavirus InfectionsRotavirus VaccinesBlood Group AntigensRotavirusInfantInfant, NewbornHumansIndonesiaGenotype

Stichwörter der Autor:innen

Indonesiahisto-blood group antigenneonatal vaccinationrotavirusvaccine take

Substanzen

Rotavirus VaccinesBlood Group Antigens

Autor:innen und Institutionen

  • Enteric Diseases Group, Murdoch Children's Research Institute.
  • Department of Paediatrics, The University of Melbourne, Parkville.
  • Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne.
  • Medicines Development for Global Health, Southbank.
  • Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
  • Department of Pharmacology and Therapy.

ORCID-Profile: Celeste M Donato

Förderung

  • Gates Foundation
  • Bill & Melinda Gates Foundation
  • National Health and Medical Research Council
  • PT Bio Farma
  • Victorian Government’s Operational Infrastructure Support Program
  • Early Career Fellowship

Zitieren

APA

Donato, C. M., Handley, A., Byars, S. G., Bogdanovic-Sakran, N., Lyons, E. A., Watts, E., Ong, D. S., Pavlic, D., At Thobari, J., Satria, C. D., Nirwati, H., Soenarto, Y., & Bines, J. E. (2024). Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad351

Vancouver

Donato CM, Handley A, Byars SG, Bogdanovic-Sakran N, Lyons EA, Watts E, et al. Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad351

BibTeX
@article{Donato2024,
  author = {Donato, Celeste M and Handley, Amanda and Byars, Sean G and Bogdanovic-Sakran, Nada and Lyons, Eleanor A and Watts, Emma and Ong, Darren S and Pavlic, Daniel and At Thobari, Jarir and Satria, Cahya Dewi and Nirwati, Hera and Soenarto, Yati and Bines, Julie E},
  title = {Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad351}
}
Kostenlos starten →